RAMELTEON
Generic: RAMELTEON
Upsher-Smith LaboratoriesManufacturer
ORALRoute
RAMELTEONActive Substance
2020-10-26Original Approval
RAMELTEON is FDA application ANDA213815, sponsored by APPCO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
82 reports
2
OFF LABEL USE
76 reports
3
NAUSEA
72 reports
4
DIARRHOEA
71 reports
5
DECREASED APPETITE
66 reports
6
INSOMNIA
63 reports
7
FATIGUE
55 reports
8
PNEUMONIA
54 reports
9
FALL
50 reports
10
VOMITING
50 reports